Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?
about
Amitriptyline for neuropathic pain in adultsMilnacipran for neuropathic pain in adultsOral nonsteroidal anti-inflammatory drugs for neuropathic painAcupuncture for neuropathic pain in adultsNortriptyline for neuropathic pain in adultsMorphine for neuropathic pain in adultsAntidepressant drugs for neuropathic pain - an overview of Cochrane reviewsHydromorphone for neuropathic pain in adultsBuprenorphine for neuropathic pain in adultsFentanyl for neuropathic pain in adultsOral nonsteroidal anti-inflammatory drugs for neuropathic painSafety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofenPrevention strategies for herpes zoster and post-herpetic neuralgiaMicroglial TNFα Induces COX2 and PGI2 Synthase Expression in Spinal Endothelial Cells during Neuropathic Pain.Role of spinal cyclooxygenase in human postoperative and chronic pain.Fentanyl for neuropathic pain in adults.Fisetin exerts antihyperalgesic effect in a mouse model of neuropathic pain: engagement of spinal serotonergic systemCharacterization of a new animal model for evaluation and treatment of back pain due to lumbar facet joint osteoarthritisDoes menopausal hormone therapy (MHT), exercise or a combination of both, improve pain and function in post-menopausal women with greater trochanteric pain syndrome (GTPS)? A randomised controlled trial.Pharmacological modulation of neuropathic pain-related depression of behavior: effects of morphine, ketoprofen, bupropion and [INCREMENT]9-tetrahydrocannabinol on formalin-induced depression of intracranial self-stimulation in rats.HCN1 channels as targets for anesthetic and nonanesthetic propofol analogs in the amelioration of mechanical and thermal hyperalgesia in a mouse model of neuropathic pain.SCISSOR-Spinal Cord Injury Study on Small molecule-derived Rho inhibition: a clinical study protocol.The antinociceptive effects of ferulic acid on neuropathic pain: involvement of descending monoaminergic system and opioid receptors.Neuropathic pain and pharmacological treatment.Emerging drugs for neuropathic pain.Prior authorization in the treatment of patients with pDPN and FM.Expert opinion on emerging drugs: chronic low back pain.Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents.Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults.Treatment of Neuropathic Pain.Acupuncture for neuropathic pain in adults.Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor.Effects of intermedin on dorsal root ganglia in the transmission of neuropathic pain in chronic constriction injury rats.Curcumin alleviates pain and improves cognitive impairment in a rat model of cobra venom-induced trigeminal neuralgia.Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.
P2860
Q24186538-7F94E034-C9FC-41AA-88B1-2C20DE21D1A7Q24186555-22072774-E2AC-4843-A7D0-D41B8DC57D08Q24186621-8BF522C2-A136-46AC-901C-0CA60BF8596DQ24186657-4091BA12-0CBC-4C0E-A15A-F54E874DFA32Q24186696-BCFABC9C-B421-42D5-9111-3CF4D629DD9AQ24186741-F314C8E4-0A9F-488B-9954-D30ACB344AB3Q24186993-52DDDC4E-E4DE-4DC5-8ECA-30E3563C4B77Q24187550-9FD7B7BE-9198-4EB6-BF53-63B6FE5FC4E8Q24187555-5FF0D7E4-1F4D-4BC8-BC0E-AD7C4D7A7E3EQ24187562-12749938-6871-44C0-A86F-E9A53C779794Q24202080-C29EAE06-E506-4F12-BA34-D7629B79AAD1Q28385294-20AF3F15-DB1E-4126-BC86-1421B107AE4EQ33562809-394A6F6F-3438-461C-B3F2-690D624ABE5DQ33588645-DE147164-4154-48A3-9DA5-E2D93539A9B9Q33942912-BB3FE423-9229-45B9-987C-A1E601CFFDC9Q34542356-DA44B6E1-46F3-4C6D-846D-B25A83C92855Q35169472-FC55C968-09C2-4977-9A27-85F8A7527ACDQ35275830-8269672B-0AD5-422A-8C4F-EBCE98C64BFDQ36054925-EFB8CD5D-AAA2-42F3-9B98-DB9017E0368AQ36828445-58A66F3A-C831-4CFF-AF31-200B2994ACE8Q36852584-08926392-A62D-45CA-A9D2-5D373AEC02D5Q37133751-37CD8B36-A418-4140-948F-A81A2AEFEDD5Q37190334-6F2C67DF-173B-4711-B3A2-5B76DA25CFA1Q38113229-6A20AD5A-0DF1-4DD6-BA11-DCBAE363C08EQ38209093-76AC5A98-BE2C-439F-9951-02C34DE30BDEQ38267189-F10974B8-431C-4B19-8886-83BF81BA3E2DQ38292223-104A8C68-B3D0-4F44-890C-D0DDA00BCDC0Q38644858-B42944C9-8756-40F0-8F21-7431F8B8F4F0Q38664977-45BB8CC2-7E75-432F-ADB5-C5B8B9E834B2Q38871845-1321B0A0-B87E-4A9A-A068-179BFCA2B423Q39181518-13C39074-E732-44B0-8AE9-A9072EC365B4Q47380824-052FECD4-070D-4DED-8248-13BCDD6617A2Q48392103-08A7F332-EB32-43F8-8415-A9BAA76D2E44Q54163600-DE1FAC00-6758-40AA-9A41-16EB834758B2Q55311374-A504C326-5E03-4150-8A11-FE11A5BE4695Q55535831-E0B022AA-770E-4D0C-9DD1-CE1DA5152A53
P2860
Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-steroidal anti-inflammator ...... lain continued widespread use?
@en
Non-steroidal anti-inflammator ...... lain continued widespread use?
@nl
type
label
Non-steroidal anti-inflammator ...... lain continued widespread use?
@en
Non-steroidal anti-inflammator ...... lain continued widespread use?
@nl
prefLabel
Non-steroidal anti-inflammator ...... lain continued widespread use?
@en
Non-steroidal anti-inflammator ...... lain continued widespread use?
@nl
P2093
P1433
P1476
Non-steroidal anti-inflammator ...... lain continued widespread use?
@en
P2093
Andrew S C Rice
Robert H Dworkin
P304
P356
10.1016/J.PAIN.2009.03.013
P407
P577
2009-04-10T00:00:00Z